Status:
WITHDRAWN
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
Lead Sponsor:
Copenhagen University Hospital at Herlev
Conditions:
Neoplasm Metastasis
Liver
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan
Eligibility Criteria
Inclusion
- biopsy proved liver metastasis
Exclusion
- pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00718055
Start Date
November 1 2006
Last Update
February 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen Uni. Hospital at Herlev dept. of Radiology
Herlev, Denmark, 2730